Alphatec Holdings Inc ATEC

Morningstar Rating
$10.03 +0.13 (1.31%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ATEC is trading at a LOCK|dLxbg premium.
Price
$10.03
Fair Value
LOCK|.hm&X?>
Uncertainty
LOCK|^Q
1-Star Price
LOCK|.^dp?bZH
5-Star Price
LOCK|&PBF?!#
Economic Moat
LOCK|Rr
Capital Allocation
—

News

Trading Information

Previous Close Price
$9.90
Day Range
$9.80–10.18
52-Week Range
$6.82–23.29
Bid/Ask
$9.93 / $10.15
Shares Outstanding
154.45M
Market Cap
$1.55B
Volume/Avg
2M / 2M

Key Statistics

Price/Earnings (Normalized)
132.67
Price/Sales
1.87
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
913

Valuation

Metric
ATEC
Price/Earnings (Normalized)
132.67
Price/Book Value
—
Price/Sales
1.87
Price/Cash Flow
13.50
Price/Earnings
ATEC

Financial Strength

Metric
ATEC
Quick Ratio
0.96
Current Ratio
1.89
Interest Coverage
−1.26
Quick Ratio
ATEC

Profitability

Metric
ATEC
Return on Assets (Normalized)
3.19%
Return on Equity (Normalized)
416.96%
Return on Invested Capital (Normalized)
10.55%
Return on Assets
ATEC

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|!>SySCLOCK|D?T@$169B
Medtronic PLC
MDT
LOCK|d$g>??LOCK|rPS@P$110B
Stryker Corp
SYK
LOCK|DbWw<@!WLOCK|xR$106B
Boston Scientific Corp
BSX
LOCK|d<s!?rNLOCK|j&&!&$62B
Edwards Lifesciences Corp
EW
LOCK|g#s>@fq<LOCK|%z$y>$49B
DexCom Inc
DXCM
LOCK|px$fcXPgLOCK|#PPf$32B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|xFF&Z>LOCK|lh%$29B
Koninklijke Philips NV ADR
PHG
LOCK|@L%LOCK|j!$$23B
Steris PLC
STE
LOCK|!%RB^TrLOCK|%D&n$20B
Zimmer Biomet Holdings Inc
ZBH
LOCK|x!q^Dv%LOCK|$RJ$17B

Sponsor Center